Comprehensive Review of Antihypertensive Therapy: Pathophysiology, Diagnosis, and Management
Authors
Alana Akmal YuarDOI:
10.29303/jbt.v25i4.10470Published:
2025-10-27Issue:
Vol. 25 No. 4 (2025): in ProgressKeywords:
Antihypertensive, Non-pharmacological therapy, Pharmacological therapyArticles
Downloads
How to Cite
Downloads
Abstract
Hypertension is fundamentally defined as a medical condition characterized by persistent elevations in systemic blood pressure. Various approaches to address hypertension include pharmacological and non-pharmacological therapies. This literature review aims to comprehensively review antihypertensive therapy: pathophysiology, diagnosis, and management. This article was compiled using a literature review method and developed using the PRISMA approach. The findings indicate that hypertension therapy can be carried out in two ways: pharmacological and non-pharmacological. Non-pharmacological therapy through lifestyle interventions is not only effective in lowering blood pressure but also provides overall health benefits. The main components of non-pharmacological interventions include dietary modification, physical activity, weight management, and cessation of detrimental habits such as smoking and excessive alcohol consumption. Pharmacological therapy is based on two main factors: blood pressure levels and the patient's total cardiovascular risk profile. Modern treatment strategies strongly recommend the use of combination therapy as an initial step in most patients. The recommended combination is a renin-angiotensin system (RAS) blocker (ACE inhibitor or ARB) with a calcium channel blocker (CCB) or a diuretic. A new and emerging pharmacological approach is more comprehensive RAAS inhibition. In conclusion, hypertension therapy can be carried out in 2 ways, namely non-pharmacological therapy and pharmacological therapy.
References
Abuhasira, R., Burrack, N., Turjeman, A., Patt, Y. S., Leibovici, L., & Grossman, A. (2025). Comparative analysis of first-line antihypertensive treatment classes. The American Journal of Medicine, 138(3), 449-457. https://doi.org/10.1016/j.amjmed.2024.10.016.
Ainurrafiq, A., Risnah, R., & Azhar, M. U. (2019). Terapi non farmakologi dalam pengendalian tekanan darah pada pasien hipertensi: Systematic review. Media Publikasi Promosi Kesehatan Indonesia (MPPKI), 2(3), 192-199.
Aralica, M., Šupak-Smolčić, V., Honović, L., Franin, L., Šonjić, P., Šimac, M., ... & Poropat, N. (2023). Laboratory medicine in arterial hypertension. Biochemia medica, 33(1), 10-20. https://doi.org/10.11613/BM.2023.010501.
Carey, R.M., Moran, A.E. and Whelton, P.K. (2022) ‘Treatment of Hypertension: A Review’, Jama, 328(18), pp. 1849–1861. Available at: https://doi.org/10.1001/jama.2022.19590.
Carnovale, C., Perrotta, C., Baldelli, S., Cattaneo, D., Montrasio, C., Barbieri, S. S., ... & Pozzi, M. (2023). Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects. Cardiovascular research, 119(3), 647-667. https://doi.org/10.1093/cvr/cvac110.
Chaudhry, R., Siddique, Y. A., Sebai, A., Moazam, M. M., Virk, G. S., Tamene, Y., & Hassouba, M. (2024). The efficacy of antihypertensive drugs in lowering blood pressure and cardiovascular events in the elderly population: a systematic review and meta-analysis. Cureus, 16(1). https://doi.org/10.7759/cureus.52053.
Chen, R., Suchard, M. A., Krumholz, H. M., Schuemie, M. J., Shea, S., Duke, J., ... & Hripcsak, G. (2021). Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study. Hypertension, 78(3), 591-603. https://doi.org/10.1161/HYPERTENSIONAHA.120.16667.
Coca, A., Whelton, S. P., Camafort, M., López-López, J. P., & Yang, E. (2024). Single-pill combination for treatment of hypertension: Just a matter of practicality or is there a real clinical benefit?. European Journal of Internal Medicine, 126, 16-25. https://doi.org/10.1016/j.ejim.2024.04.011.
Ding, H., Liu, S., Zhao, K. X., Pu, J., Xie, Y. F., & Zhang, X. W. (2022). Comparative Efficacy of Antihypertensive Agents in Flow‐Mediated Vasodilation of Patients with Hypertension: Network Meta‐Analysis of Randomized Controlled Trial. International journal of hypertension, 2022(1), 2432567.
Dzau, V.J. and Hodgkinson, C.P. (2024) ‘Precision Hypertension’, Hypertension, 81(4), pp. 702–708. Available at: https://doi.org/10.1161/HYPERTENSIONAHA.123.21710.
Gallo, G. and Savoia, C. (2024) ‘Hypertension and Heart Failure: From Pathophysiology to Treatment’, International Journal of Molecular Sciences, 25(12). Available at: https://doi.org/10.3390/ijms25126661.
Goorani, S., Zangene, S. and Imig, J.D. (2025) ‘Hypertension: A Continuing Public Healthcare Issue’, International Journal of Molecular Sciences, 26(1), pp. 1–18. Available at: https://doi.org/10.3390/ijms26010123.
Harrison, D.G., Coffman, T.M. and Wilcox, C.S. (2021) ‘Pathophysiology of Hypertension: The Mosaic Theory and Beyond’, Circulation Research, 128(7), pp. 847–863. Available at: https://doi.org/10.1161/CIRCRESAHA.121.318082.
Huang, L., Zhang, Y., Xing, L., Li, P. Q., Chu, H. Q., He, C. X., ... & Cao, H. L. (2024). Pharmacological Research Progress of Novel Antihypertensive Drugs. Discovery Medicine, 36(184), 882-897. https://doi.org/10.24976/discov.med.202436184.83.
Johnson, H. M., Shimbo, D., ... & Williamson, J. D. (2025). 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 152(11), e114-e218. https://doi.org/10.1161/CIR.0000000000001356.
Kario, K., Okura, A., Hoshide, S., & Mogi, M. (2024). The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertension Research, 47(5), 1099-1102. https://doi.org/10.1038/s41440-024-01622-w.
Laurent, S. (2017). Antihypertensive drugs. Pharmacological research, 124, 116-125.
Litwin, M. (2024) ‘Pathophysiology of primary hypertension in children and adolescents’, Pediatric Nephrology, 39(6), pp. 1725–1737. Available at: https://doi.org/10.1007/s00467-023-06142-2.
Litwin, M. and Kułaga, Z. (2021) ‘Obesity, metabolic syndrome, and primary hypertension’, Pediatric Nephrology, 36(4), pp. 825–837. Available at: https://doi.org/10.1007/s00467-020-04579-3.
McCarthy, C.P. et al. (2024) ‘2024 ESC Guidelines for the management of elevated blood pressure and hypertension’, European Heart Journal, 45(38), pp. 3912–4018. Available at: https://doi.org/10.1093/eurheartj/ehae178.
Panggabean, M.S. (2023) ‘Penatalaksanaan Hipertensi Emergensi, Continuing Medical Education’, 50(2), pp. 82–91.
PERHI (2019) ‘Konsensus Penatalaksanaan Hipertensi 2019’, Indonesian Society Hipertensi Indonesia, pp. 1–90.
PERKI (2015) Pedoman Tatalaksana Hipertensi Pada Penyakit Kardiovaskular. 1st edn, Physical Review D. 1st edn. Available at: https://doi.org/10.1103/PhysRevD.41.3348.
Prabhakaran, D., Roy, A., Chandrasekaran, A. M., Kondal, D., Mukherjee, S., Kiru, G., ... & Poulter, N. R. (2025). Comparison of dual therapies for hypertension treatment in India: a randomized clinical trial. Nature Medicine, 1-7. https://doi.org/10.1038/s41591-025-03854-w.
Reeve, E., Jordan, V., Thompson, W., Sawan, M., Todd, A., Gammie, T. M., ... & Gnjidic, D. (2020). Withdrawal of antihypertensive drugs in older people. Cochrane Database of Systematic Reviews, (6). https://doi.org/10.1002/14651858.CD012572.pub2.
Reinhart, M. et al. (2023) ‘Diuréticos de primera línea versus otras clases de fármacos antihipertensivos para la hipertensión’, Cochrane Database of Systematic Reviews, 2023(7). Available at: https://doi.org/10.1002/14651858.CD008161.pub3.www.cochranelibrary.com.
Schinzari, F., Montenero, R., Cardillo, C., & Tesauro, M. (2025). Emerging pharmacological approaches for the treatment of arterial hypertension. Biomedicines, 13(4), 790. https://doi.org/10.3390/biomedicines13040790.
Sitorus, T. and Simatupang, A. (2023) ‘Comparison of antihypertensive drug utilization in community health centre and type B teaching hospital’, Indonesian Journal of Pharmaceutical and Clinical Research, 6(1), pp. 25–30. Available at: https://doi.org/10.32734/idjpcr.v6i1.11982.
Smith, D.K. and Jacksonville, N.H. (2020) ‘Managing Hypertension Using Combination Therapy’, 101(6), pp. 341–349.
Sundström, J. (2023). Heterogeneity in blood pressure response to 4 antihypertensive drugs. Cardiology Research Review, (108). https://doi.org/10.1001/jama.2023.3322
License
Copyright (c) 2025 Alana Akmal Yuar

This work is licensed under a Creative Commons Attribution 4.0 International License.

Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
























